Aktuell 2024/04/03 Nouscom erhält weitere Mittel für Krebsimpfstoffe Nouscom hat eine Investition in der Höhe von 7 Millionen Euro von der italienischen Risikokapitalfirma Angelini Ventures erhalten. Damit kann das...
News 2024/04/03 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...
Recordings 2021/12/15 Swiss Peer to Peer Conference 2021 This year’s Swiss Peer to Peer Conference was more relevant than ever with discussions concerning solutions for doing business in a post-Covid-19...